These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 16618504

  • 1. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
    Föger F, Schmitz T, Bernkop-Schnürch A.
    Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
    [Abstract] [Full Text] [Related]

  • 2. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
    Föger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A.
    Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
    [Abstract] [Full Text] [Related]

  • 3. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF, Hombach J, Bernkop-Schnürch A.
    Int J Pharm; 2008 Feb 04; 348(1-2):54-60. PubMed ID: 17716840
    [Abstract] [Full Text] [Related]

  • 4. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J, Hoyer H, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2008 Jan 04; 33(1):1-8. PubMed ID: 17980561
    [Abstract] [Full Text] [Related]

  • 5. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
    Werle M, Hoffer M.
    J Control Release; 2006 Mar 10; 111(1-2):41-6. PubMed ID: 16377016
    [Abstract] [Full Text] [Related]

  • 6. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
    Iqbal J, Shahnaz G, Perera G, Hintzen F, Sarti F, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2012 Jan 10; 80(1):95-102. PubMed ID: 21964316
    [Abstract] [Full Text] [Related]

  • 7. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
    Kafedjiiski K, Hoffer M, Werle M, Bernkop-Schnürch A.
    Biomaterials; 2006 Jan 10; 27(1):127-35. PubMed ID: 16045983
    [Abstract] [Full Text] [Related]

  • 8. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
    Iqbal J, Hombach J, Matuszczak B, Bernkop-Schnürch A.
    J Control Release; 2010 Oct 01; 147(1):62-9. PubMed ID: 20603165
    [Abstract] [Full Text] [Related]

  • 9. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
    Sakloetsakun D, Iqbal J, Millotti G, Vetter A, Bernkop-Schnürch A.
    Drug Dev Ind Pharm; 2011 Jun 01; 37(6):648-55. PubMed ID: 21561400
    [Abstract] [Full Text] [Related]

  • 10. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    J Control Release; 2004 Mar 24; 95(3):547-55. PubMed ID: 15023465
    [Abstract] [Full Text] [Related]

  • 11. Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan.
    Föger F, Kafedjiiski K, Hoyer H, Loretz B, Bernkop-Schnürch A.
    J Drug Target; 2007 Feb 24; 15(2):132-9. PubMed ID: 17365284
    [Abstract] [Full Text] [Related]

  • 12. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    Int J Pharm; 2006 Jan 13; 307(2):270-7. PubMed ID: 16300914
    [Abstract] [Full Text] [Related]

  • 13. In vivo evaluation of anionic thiolated polymers as oral delivery systems for efflux pump inhibition.
    Palmberger TF, Laffleur F, Greindl M, Bernkop-Schnürch A.
    Int J Pharm; 2015 Aug 01; 491(1-2):318-22. PubMed ID: 26095915
    [Abstract] [Full Text] [Related]

  • 14. Thiolated hydroxyethylcellulose: synthesis and in vitro evaluation.
    Sarti F, Staaf A, Sakloetsakun D, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2010 Nov 01; 76(3):421-7. PubMed ID: 20833249
    [Abstract] [Full Text] [Related]

  • 15. Development and in vivo evaluation of an oral vitamin B12 delivery system.
    Sarti F, Müller C, Iqbal J, Perera G, Laffleur F, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2013 May 01; 84(1):132-7. PubMed ID: 23262165
    [Abstract] [Full Text] [Related]

  • 16. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
    Bernkop-Schnürch A, Guggi D, Pinter Y.
    J Control Release; 2004 Jan 08; 94(1):177-86. PubMed ID: 14684281
    [Abstract] [Full Text] [Related]

  • 17. Mucoadhesive properties and interaction with P-glycoprotein (P-gp) of thiolated-chitosans and -glycol chitosans and corresponding parent polymers: a comparative study.
    Trapani A, Palazzo C, Contino M, Perrone MG, Cioffi N, Ditaranto N, Colabufo NA, Conese M, Trapani G, Puglisi G.
    Biomacromolecules; 2014 Mar 10; 15(3):882-93. PubMed ID: 24521085
    [Abstract] [Full Text] [Related]

  • 18. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
    Zambito Y, Zaino C, Uccello-Barretta G, Balzano F, Di Colo G.
    Eur J Pharm Sci; 2008 Apr 23; 33(4-5):343-50. PubMed ID: 18296036
    [Abstract] [Full Text] [Related]

  • 19. In vivo evaluation of thiolated poly(acrylic acid) as a drug absorption modulator for MRP2 efflux pump substrates.
    Greindl M, Föger F, Hombach J, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2009 Aug 23; 72(3):561-6. PubMed ID: 19344758
    [Abstract] [Full Text] [Related]

  • 20. Improved paracellular uptake by the combination of different types of permeation enhancers.
    Guggi D, Bernkop-Schnürch A.
    Int J Pharm; 2005 Jan 06; 288(1):141-50. PubMed ID: 15607266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.